Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
| Revenue (Most Recent Fiscal Year) | $7.47B |
| Net Income (Most Recent Fiscal Year) | $722.43M |
| PE Ratio (Current Year Earnings Estimate) | 36.42 |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | 2.38 |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 4.76 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 35.04 |
| Pre-Tax Margin (Trailing 12 Months) | 11.47% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -- |
| Current Ratio (Most Recent Fiscal Quarter) | 1.52 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.04 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.45 |
| Inventory Turnover (Trailing 12 Months) | 2.60 |
| Book Value per Share (Most Recent Fiscal Quarter) | $14.76 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | $1.71 |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 722.26M |
| Free Float | 721.76M |
| Market Capitalization | $50.71B |
| Average Volume (Last 20 Days) | 0.05M |
| Beta (Past 60 Months) | 1.17 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.07% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.04% |
| Annual Dividend (Based on Last Quarter) | $0.11 |
| Dividend Yield (Based on Last Quarter) | 0.15% |